FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 342:216-217 January 20, 2000 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Kudenchuk, P. J. PubMed Citation

To the Editor: Kudenchuk and colleagues (Sept. 16 issue)¹ report that in patients with refractory out-of-hospital cardiac arrest, a single dose of intravenous amiodarone improves survival to hospital admission (44 percent of patients in the amiodarone group survived to admission, as compared with 34 percent of those in the placebo group). However, the best measure of the benefit of an intervention for cardiac arrest is whether it improves survival to hospital discharge. Although we acknowledge that the study by Kudenchuk and colleagues was not designed to show such a benefit, we are concerned that there was not even a trend . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.